Product analysis: the product remains implanted; therefore, no product analysis could be performed. conclusion: paravalvular leak (pvl) can be caused by a variety of factors, including valve positioning, patient anatomy, calcification level or presence of pre-existing patient conditions.In this case, it was reported that the moderate pvl was noted post implant and the valve was not fully expanded.This indicated that incomplete frame expansion could be a contributing factor for the pvl.A balloon aortic valvuloplasty (bav) was performed, pvl had reduced to trivial and it was noted that the valve had expanded.Multiple factors can affect frame expansion, such as patient anatomy (e.G., calcification location and levels) and procedure related factors (e.G., valve positioning).Based on the information provided, an assignable root cause of the frame incomplete expansion could not be conclusively determined.The device history record and associated frame lot was reviewed and showed that this device met all manufacturing specifications for final product released for distribution.No issues were identified that would have impacted this event.There is no information to suggest a device quality deficiency that may have caused or contributed to this event.During vascular closure, hypotension was noted despite medication administration.Echocardiogram revealed a mild pericardial effusion which worsened over the course of ten minutes.Hypotension is a known potential adverse effect per instructions for use (ifu).It is an effect that is highly dependent on the patient's pre-procedural condition and can occur despite a normally-functioning device or model implant procedure.Pericardial effusion is also a known effect that can occur after cardiac procedures.A conclusive cause of the hypotension and effusion could not be determined from the limited information available.In this case, a pericardiocentesis was performed and hemodynamics stabilized with no further blood loss.It was suspected that an annular tear or perforation caused the bleeding.Per the physician, it was thought that the perforation was caused by the post-implant bav.This event did not indicate device misuse or malfunction.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information that prior to the implant of this transcatheter bioprosthetic valve, a balloon aortic valvuloplasty (bav) was performed.The valve was deployed successfully on the first attempt.Aortography revealed evidence that the valve did not fully expand and echocardiogram indicated mild to moderate paravalvular leak (pvl).A post-implant bav was performed using a 24 mm non-medtronic balloon.Following bav, pvl had reduced to trivial and it was noted that the valve had expanded.During vascular closure, hypotension was noted despite medication administration.Echocardiogram revealed a mild pericardial effusion which worsened over the course of ten minutes.A pericardiocentesis was performed and hemodynamics stabilized with no further blood loss.It was suspected that an annular tear or perforation caused the bleeding.Per the physician, it was thought that the perforation was caused by the post-implant bav.No additional adverse patient effects were reported.
|